Federal Health Minister Patty Hajdu said Johnson & Johnson had submitted the COVID-19 vaccine candidate to Health Canada for approval.
It is the fourth potential vaccine submitted for evaluation in Canada and the first to require one dose to induce immunity instead of two.
Health Canada has been testing vaccine candidates from Pfizer, Moderna and AstraZeneca since October when those companies submitted a portion of their drug data for “rotational evaluation”.
If the Johnson & Johnson vaccine meets Health Canada’s standards for safety and effectiveness, the Canadian government says it has an agreement to buy 10 million doses and optionally up to 28 million.
Ontario Premier Doug Ford is expected to speak with Janssen – a Johnson & Johnson subsidiary – on Tuesday following meetings with Pfizer and AstraZeneca on Monday. He has another meeting with Moderna’s representatives scheduled for next week.
Ford said he is still looking for answers when the vaccine will be deployed.
Manufacturers Pfizer, Moderna and AstraZeneca have all filed a request for the vaccine candidates to be approved in Canada.
This content is also available in: Tiếng Việt